CSF1 and neoplasm: We recently demonstrated that pharmacological inhibition or genetic ablation of CSF1 in cancer cells reduces the accumulation of immunosuppressive CSF-1R+ tumor-associated macrophages and increases CD8+ T cell attack on tumors (Győri et al., 2018).